Purpose To assess the long-term safety and efficacy of intravitreal triamcinolone acetonide injection in the management of macular oedema caused by central, hemi-, and branch retinal vein occlusion (CRVO, HRVO, or BRVO). Methods This prospective, interventional case series included 13 patients (13 eyes) with retinal vein occlusion and macular oedema.